Y Intercept Hong Kong Ltd Buys New Position in Ultralife Corporation $ULBI

Y Intercept Hong Kong Ltd bought a new position in Ultralife Corporation (NASDAQ:ULBIFree Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 28,809 shares of the technology company’s stock, valued at approximately $259,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Janney Montgomery Scott LLC grew its position in shares of Ultralife by 1.1% during the 2nd quarter. Janney Montgomery Scott LLC now owns 446,250 shares of the technology company’s stock worth $4,007,000 after buying an additional 5,000 shares during the period. Nuveen LLC bought a new position in Ultralife during the first quarter worth $116,000. Jones Financial Companies Lllp grew its holdings in Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after purchasing an additional 14,287 shares during the period. IFP Advisors Inc increased its stake in Ultralife by 24.6% in the first quarter. IFP Advisors Inc now owns 14,200 shares of the technology company’s stock valued at $76,000 after purchasing an additional 2,800 shares in the last quarter. Finally, Bank of America Corp DE increased its stake in Ultralife by 30.7% in the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock valued at $90,000 after purchasing an additional 2,836 shares in the last quarter. 30.68% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ULBI. Wall Street Zen cut shares of Ultralife from a “strong-buy” rating to a “hold” rating in a research report on Saturday, September 13th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Ultralife in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $14.00.

View Our Latest Research Report on ULBI

Insider Buying and Selling at Ultralife

In related news, Director Bradford T. Whitmore bought 29,766 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were bought at an average price of $6.63 per share, for a total transaction of $197,348.58. Following the completion of the acquisition, the director directly owned 1,128,731 shares of the company’s stock, valued at $7,483,486.53. This trade represents a 2.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders purchased a total of 58,664 shares of company stock valued at $387,049 in the last 90 days. 40.00% of the stock is owned by company insiders.

Ultralife Trading Down 1.7%

NASDAQ:ULBI opened at $6.75 on Friday. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.31 and a quick ratio of 1.62. Ultralife Corporation has a one year low of $4.07 and a one year high of $9.52. The company has a market cap of $112.35 million, a PE ratio of 35.53 and a beta of 1.02. The firm has a 50-day moving average of $6.87 and a 200-day moving average of $7.03.

Ultralife (NASDAQ:ULBIGet Free Report) last announced its quarterly earnings results on Thursday, August 7th. The technology company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.07). The business had revenue of $48.56 million during the quarter, compared to the consensus estimate of $51.00 million. Ultralife had a net margin of 1.79% and a return on equity of 2.68%.

About Ultralife

(Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Read More

Want to see what other hedge funds are holding ULBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ultralife Corporation (NASDAQ:ULBIFree Report).

Institutional Ownership by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.